Cerebrospinal fluid antiganglioside antibodies in patients with AIDS

This publication has 18 references indexed in Scilit:

• Autoantibodies Against Ganglioside GM3 Represent a Portion of Anti‐Lymphocyte Antibodies in AIDS Patients
  Scandinavian Journal of Immunology, 1994
• GM3 as a Target of Anti-lymphocytic Ganglioside Antibodies in AIDS Patients
  Clinical Immunology and Immunopathology, 1993
• Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy
  Journal of the Neurological Sciences, 1993
• Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation.
  Journal of Clinical Investigation, 1992
• Cerebrospinal fluid markers for the monitoring of AIDS dementia complex severity
  AIDS, 1991
• Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid
  The Lancet, 1991
• The spectrum of neurologic disease associated with anti‐GM ₁ antibodies
  Neurology, 1990
• Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin
  Acta Neuropathologica, 1986
• Intra-Blood–Brain-Barrier Synthesis of HTLV-III-Specific IgG in Patients with Neurologic Symptoms Associated with AIDS or AIDS-Related Complex
  New England Journal of Medicine, 1985
• Anti-ganglioside antibodies in multiple sclerosis
  Journal of the Neurological Sciences, 1980